Update 12:55 p.m.: According to the AFP news agency, approval of the vaccine before Christmas in Europe is anything but certain. More on this: click here. According to media reports, the COVID-19 vaccine BNT162b2 from BioNTech and Pfizer should receive approval in the European Union in the coming week. This is reported by several media, including the FAZ citing government circles. BNT162b2 is already approved in the USA and also in Great Britain – vaccinations are already in progress here.
The reports are so far unconfirmed and various also not very clear from a technical point of view. For example, there is talk of approval of the vaccine by the European Medicines Agency (EMA) – although approval is formally granted by the European Commission. This usually adheres to the EMA recommendation and is likely to react to its decision at short notice.
In the EU, vaccinations are to begin shortly after approval – these could start on Boxing Day. The plan was initially to vaccinate primarily risk groups and, among others, people who work in vulnerable professions such as nursing.
BioNTech and Pfizer, as well as the EMA, have not yet commented on the reports.
Livestream on December 14th, 2020 from 6 p.m .:
With Hans-Werner Sinn, former President of the Ifo Institute: Corona and the miraculous increase in money in Europe
– Here is the stream! –